Cardiovascular Outcomes Trials for Weight Loss Interventions: Another Tool for Cardiovascular Prevention?-Reference-Cited by-同舟云学术

Cardiovascular Outcomes Trials for Weight Loss Interventions: Another Tool for Cardiovascular Prevention?

Published:2021-10-26 Issue:17 Volume:144 Page:1359-1361
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Neeland Ian J.¹^ORCID,McGuire Darren K.²,Sattar Naveed³

Affiliation:

1. University Hospitals Harrington Heart and Vascular Institute and Case Western Reserve University School of Medicine, Cleveland, OH (I.J.N.).

2. Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center and Parkland Health and Hospital System, Dallas (D.K.M.).

3. Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom (N.S.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056742

Reference5 articles.

1. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial

2. Bariatric Surgery and Cardiovascular Outcomes in Patients With Obesity and Cardiovascular Disease:

3. Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study

4. Once-Weekly Semaglutide in Adults with Overweight or Obesity

5. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or obese non-diabetic patients;Current Problems in Cardiology;2024-03

2. Inter‐relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management;Diabetes, Obesity and Metabolism;2024-02-08

3. Independent relevance of adiposity measures to coronary heart disease risk among 0.5 million adults in UK Biobank;International Journal of Epidemiology;2023-11-04

4. Predicted but not destined: considerations for obesity-related cardiovascular risk projection;The Lancet Regional Health - Western Pacific;2023-08

5. Time and event-specific deep learning for personalized risk assessment after cardiac perfusion imaging;npj Digital Medicine;2023-05-01